<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   853
  </number>
  <updateDate>
   2023-01-11T13:46:52Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:46:52Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-02-04
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 21 (Thursday, February 4, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. WELCH:H.R. 853.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 18: The Congress shall havePower To . . . make all Laws which shall be necessary andproper for carrying into Execution the foregoing Powers, andall other Powers vested by this Constitution in theGovernment of the United States, or in any Department orOfficer therof . . .[Page H388]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-05T20:34:43Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-02-04T15:07:10Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-02-05
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-02-04
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-02-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-02-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     W000800
    </bioguideId>
    <fullName>
     Rep. Welch, Peter [D-VT-At Large]
    </fullName>
    <firstName>
     Peter
    </firstName>
    <lastName>
     Welch
    </lastName>
    <party>
     D
    </party>
    <state>
     VT
    </state>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     M001180
    </bioguideId>
    <fullName>
     Rep. McKinley, David B. [R-WV-1]
    </fullName>
    <firstName>
     David
    </firstName>
    <lastName>
     McKinley
    </lastName>
    <party>
     R
    </party>
    <state>
     WV
    </state>
    <middleName>
     B.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-02-04
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Drug therapy
     </name>
    </item>
    <item>
     <name>
      Health care costs and insurance
     </name>
    </item>
    <item>
     <name>
      Inflation and prices
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-02-04
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-03-17T16:27:51Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Closing Loopholes for Orphan Drugs Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill revises the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program. &lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Closing Loopholes for Orphan Drugs Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Closing Loopholes for Orphan Drugs Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Closing Loopholes for Orphan Drugs Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-02-04T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr853ih/xml/BILLS-117hr853ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-02-05
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-02-05
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-04
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-04
9
Library of Congress
Introduced in House
IntroReferral
2021-02-04T15:07:10Z
Referred to
House
Energy and Commerce Committee
2021-02-05T20:34:43Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
M001180
1
David
Rep. McKinley, David B. [R-WV-1]
McKinley
B.
R
2021-02-04
WV
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-02-04
2021-02-05
Referred to the Subcommittee on Health.
House
Health
W000800
Peter
Rep. Welch, Peter [D-VT-At Large]
N
Welch
D
VT
Drug therapy Health care costs and insurance Inflation and prices Prescription drugs
2021-02-04
Introduced in House
 <p><b>Closing Loopholes for Orphan Drugs Act</b></p> <p>This bill revises the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program. </p>
2021-03-17T16:27:51Z
00
2021-02-04T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr853ih/xml/BILLS-117hr853ih.xml
Closing Loopholes for Orphan Drugs Act
Closing Loopholes for Orphan Drugs Act
Display Title
IH
Introduced in House
To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.
Official Title as Introduced
IH
Introduced in House
Closing Loopholes for Orphan Drugs Act
Short Title(s) as Introduced
HR
2023-01-11T13:46:52Z
2023-01-11T13:46:52Z
3.0.0
2021-02-05
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-04
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-04
9
Library of Congress
Introduced in House
IntroReferral
W000800
Peter
Rep. Welch, Peter [D-VT-At Large]
N
Welch
D
VT
M001180
1
David
Rep. McKinley, David B. [R-WV-1]
McKinley
B.
R
2021-02-04
WV
Drug therapy Health care costs and insurance Inflation and prices Prescription drugs
2021-02-04
Introduced in House
 <p><b>Closing Loopholes for Orphan Drugs Act</b></p> <p>This bill revises the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program. </p>
2021-03-17T16:27:51Z
00
Closing Loopholes for Orphan Drugs Act
Closing Loopholes for Orphan Drugs Act
Display Title
IH
Introduced in House
To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.
Official Title as Introduced
IH
Introduced in House
Closing Loopholes for Orphan Drugs Act
Short Title(s) as Introduced
2021-02-05
Referred to the Subcommittee on Health.